Iwanaga T, Chiba T, Nakamura M, Kaneko T, et al. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-beta/Smad pathway suppression in hepatic stellate cells. Biochem Biophys Res Commun 2022;642:192-200.
PMID: 36586187